11:25 AM EST, 11/22/2024 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Friday as they head for weekly gains.

In company news, Intuit (INTU) reported fiscal Q1 non-GAAP earnings late Thursday of $2.50 per diluted share, up from $2.47 a year earlier and above the consensus estimate from analysts surveyed by FactSet of $2.36 excluding certain items. Fiscal Q1 revenue was $3.28 billion, up from $2.98 billion in the year-ago period and above the FactSet consensus of $3.14 billion. For fiscal Q2, the company expects non-GAAP EPS of $2.55 to $2.61 on revenue of $3.81 billion to $3.85 billion. Analysts polled by FactSet expect $3.25 and $3.88 billion, respectively. Intuit shares were down 4.7% around midday.

Honeywell International ( HON ) agreed to sell its personal protective equipment business to a portfolio company of private equity firm Odyssey Investment Partners in an all-cash deal valued at about $1.33 billion. The transaction is expected to be complete in H1 2025, the companies said in separate statements. Honeywell ( HON ) will retain its gas detection portfolio within the industrial automation business. Honeywell ( HON ) shares were up 1.0%.

The US Supreme Court on Friday declined to consider an appeal by Meta Platforms' ( META ) Facebook, meaning it will have to face a lawsuit accusing it of misleading shareholders regarding the 2015 data breach involving Cambridge Analytica. Meta shares were down 1.2%.

Amazon.com ( AMZN ) said Friday that it is making an additional $4 billion investment in Anthropic and that the artificial intelligence company has named Amazon Web Services its primary training partner. Amazon ( AMZN ) shares were down 0.4%.

The mobile ecosystem activities of Apple ( AAPL ) and Alphabet's (GOOG, GOOGL) Google ( GOOG ) should be investigated by the UK's Competition and Markets Authority, according to the provisional findings of the regulator's independent inquiry group published on Friday. Apple ( AAPL ) shares were up 0.3%, while those of Alphabet were down 1.7%.

Merck's ( MRK ) asthma drug Singulair, now manufactured by Merck ( MRK ) spin-off Organon, and generic versions of montelukast have been linked to serious mental health problems from some users in a US Food and Drug Administration study, Reuters reported Friday, citing a scientific presentation it reviewed. Merck ( MRK ) shares were up 1.3%.

Price: 228.50, Change: +2.41, Percent Change: +1.07